Skip to main content
UniHealth

Doctor search

Chadwick W Christine, MD

Neurology · San Francisco

NPI 1437186855

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
9
1 carrier
Offices
5
Since medical school
35 years
Js Weill Medical College, Cornell University, 1991

Offices

5 locations · UCSF Medical Group Business Services · University of California San Francisco

Looking this up.

Hospitals listed: Marinhealth Medical Center · UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Christine’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence G76788 · Current

Licensed to practise in California · since 1993 · expires 2027-05-31 · Cornell University Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Psychiatry and Neurology - Neurology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Marinhealth Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.66 (3.59 to 7.73) · 1,505 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.177BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.85 (0 to 1.83) · 1,056 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.04 (0.72 to 1.36)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.34 (112.58 to 222.09) · 57 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 47 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.5 · 119 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.6 · 257 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 428 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.4 · 477 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.3 · 197 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,827 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.38) · 6,990 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.41) · 6,838 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.41 (0 to 3) · 664 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.86 (1.4 to 4.33) · 1,436 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.38 (3.68 to 17.08) · 705 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.38 (0.72 to 8.04) · 672 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.18 to 3.15) · 300 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.56 (0 to 1.25) · 5,550 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 76 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.396No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 275 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 427 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-20.3 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits3.3 · 494 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-4.9 · 499 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.9 · 435 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.5 (3.6 to 8.4) · 93 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.2 (7.8 to 16) · 93 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.6 · 84 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 111 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (10.3 to 16.5) · 2,119 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.8 to 1.4) · 670 casesNo differentJan 2024 – Dec 2024

What patients said (1,233 patients answered, 19% of those asked)

Patient survey stars by topic at Marinhealth Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Marinhealth Medical Center
Room was "always" clean68%
Nurses "always" communicated well73%
Doctors "always" communicated well74%
Staff "always" explained56%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully72%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications70%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully68%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night48%
"YES", patients would definitely recommend the hospital76%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms85%
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$45,842

Medicare paid this office $45,842 for 287 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)110$15,107$114
Return visit (30+ min)139$14,054$76
Short return visit (20+ min)100$6,191$50
New patient visit (60+ min)23$3,546$154
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's158$3,375$14
See all 6 services
Every Original Medicare service billed
Long return visit (40+ min)110$15,107$114
Return visit (30+ min)139$14,054$76
Short return visit (20+ min)100$6,191$50
New patient visit (60+ min)23$3,546$154
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's158$3,375$14
New patient visit (45+ min)25$2,581$103

Who their Medicare patients are

287 Original Medicare patients in 2024. Average age 77 · Women 37% · Also on Medicaid 14% · Health risk score 1.49. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 61% · Depression 47% · Coronary heart disease 24% · Chronic kidney disease 17% · Dementia 17% · Diabetes 15% · Cancer 14% · Atrial fibrillation 14% · Heart failure 10% · COPD 9% · Stroke 9%.

The office billed $327,906, Medicare allowed $64,803 and paid $45,842; for 744 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024287744771.49$327,906$45,842
2023289534771.44$324,789$44,288
2022339617761.41$382,206$52,522
2021407692761.36$488,689$68,677
2020373623751.52$420,160$47,152
2019423768751.57$524,967$60,296
2018428733751.48$478,958$54,568
2017432773741.54$480,661$60,699
2016452786741.57$467,880$59,340
2015468839731.61$509,064$65,597
2014427781731.55$470,074$61,693
2013398698731.46$366,757$48,039

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Long return visit (40+ min)111$16,644$112
Return visit (30+ min)155$16,171$76
Short return visit (20+ min)92$6,221$52
New patient visit (60+ min)22$2,976$135
New patient visit (45+ min)13$1,399$108

2022: 5 services

Original Medicare services billed in 2022
Return visit (30+ min)204$22,878$77
Long return visit (40+ min)116$16,713$113
Short return visit (20+ min)92$5,587$49
New patient visit (60+ min)28$4,461$159
New patient visit (45+ min)21$2,398$114

2021: 5 services

Original Medicare services billed in 2021
Long return visit (40+ min)184$29,606$114
Return visit (30+ min)204$21,440$76
New patient visit (60+ min)82$12,615$154
New patient visit (45+ min)20$2,316$116
Short return visit (20+ min)36$2,309$58

2020: 6 services

Original Medicare services billed in 2020
Return visit (30+ min)256$22,530$60
Long return visit (40+ min)79$8,378$89
New patient visit (60+ min)62$8,021$129
New patient visit (45+ min)12$1,145$95
Return visit (30+ min)12$749$62
Short return visit (20+ min)15$321$21

2019: 7 services

Original Medicare services billed in 2019
Return visit (30+ min)256$24,663$62
Long return visit (40+ min)130$12,681$77
New patient visit (60+ min)58$8,352$144
New patient visit (45+ min)20$2,089$104
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes12$1,962$93
Short return visit (20+ min)31$1,517$43
New patient visit (30+ min)13$883$68

2018: 4 services

Original Medicare services billed in 2018
Return visit (30+ min)263$24,483$58
Long return visit (40+ min)142$15,478$83
New patient visit (60+ min)85$11,518$136
New patient visit (45+ min)22$2,264$103

2017: 6 services

Original Medicare services billed in 2017
Return visit (30+ min)235$21,461$58
Long return visit (40+ min)161$17,518$85
New patient visit (60+ min)69$9,778$142
New patient visit (45+ min)36$3,630$101
New patient visit (30+ min)13$881$68
Short return visit (20+ min)16$683$43

2016: 8 services

Original Medicare services billed in 2016
Return visit (30+ min)271$26,831$60
Long return visit (40+ min)126$13,260$86
New patient visit (60+ min)55$7,375$134
Initial hospital care with moderate level of medical decision making at least 75 minutes24$4,314$180
New patient visit (45+ min)27$2,822$105
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes21$2,562$64
New patient visit (30+ min)12$738$61
Short return visit (20+ min)11$279$25

2015: 7 services

Original Medicare services billed in 2015
Return visit (30+ min)288$31,814$62
Long return visit (40+ min)112$12,625$90
New patient visit (60+ min)81$11,305$140
New patient visit (45+ min)25$2,678$107
Initial hospital care with moderate level of medical decision making at least 75 minutes13$2,325$179
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$1,040$65
New patient visit (30+ min)14$890$64

2014: 6 services

Original Medicare services billed in 2014
Return visit (30+ min)271$31,454$62
New patient visit (60+ min)81$11,115$137
Long return visit (40+ min)75$7,937$92
New patient visit (45+ min)25$2,905$116
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,710$181
Short return visit (20+ min)18$823$43

2013: 4 services

Original Medicare services billed in 2013
Return visit (30+ min)282$30,535$58
New patient visit (60+ min)68$9,187$135
New patient visit (45+ min)39$4,302$110
Long return visit (40+ min)27$2,377$88

Drugs they prescribed that Part D paid

$1,332,240

Pharmacies billed $1,332,240 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 3,728) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

3,294 generic and 434 brand-name prescriptions · $1,332,240 in drug cost · 246 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
NuplazidParkinson's psychosis115$551,636$4,797
RytaryParkinson's117$254,589$2,176
GocovriNone50$143,444$2,869
TolcaponeNone12$61,218$5,102
NourianzNone23$57,739$2,510
See all 42 drugs
Every Part D drug this clinician prescribed
NuplazidParkinson's psychosis115$551,636$4,797
RytaryParkinson's117$254,589$2,176
GocovriNone50$143,444$2,869
TolcaponeNone12$61,218$5,102
NourianzNone23$57,739$2,510
Rasagiline MesylateNone178$44,653$251
Carbidopa-Levodopa ErNone551$40,590$74
Carbidopa-LevodopaNone630$35,488$56
Carbidopa-Levodopa-EntacaponeNone50$18,205$364
EntacaponeNone61$15,931$261
AmantadineNone178$12,495$70
ModafinilNone12$8,938$745
RivastigmineNone37$8,160$221
GabapentinNone185$4,279$23
DonepezilNone308$3,916$13
Ropinirole ErNone20$3,642$182
RivastigmineNone44$3,518$80
MidodrineNone64$3,152$49
Bupropion XlNone74$2,061$28
RopiniroleNone45$1,995$44
EscitalopramNone97$1,878$19
MirtazapineNone78$1,874$24
Pramipexole DihydrochlorideNone69$1,502$22
DoxepinNone25$1,245$50
Fludrocortisone AcetateNone21$1,178$56
QuetiapineNone102$1,150$11
TrazodoneNone79$1,107$14
GlycopyrrolateNone29$1,024$35
Propranolol Hcl ErNone12$799$67
SertralineNone66$789$12
PropranololNone23$559$24
ClozapineNone29$545$19
Venlafaxine Hcl ErNone18$431$24
ParoxetineNone16$421$26
PrimidoneNone14$372$27
BupropionNone20$359$18
ClonazepamNone46$326$7
Citalopram HbrNone38$288$8
ZonisamideNone18$190$11
DiazepamNone14$48$3
TrihexyphenidylNone13$33$3
LorazepamNone12$24$2

Year by year

Part D prescribing by year
20243,7283350% (0)12%$1,332,240
20233,9253490% (0)11%$1,381,734
20224,2283980% (0)10%$1,314,769
20214,4444370% (0)None$1,070,859
20204,2614320% (0)10%$1,002,824
20194,3164340% (0)11%$946,697
20184,4554360% (0)13%$1,028,340
20174,448420None14%$1,203,738
20164,5364010% (0)18%$1,016,925
20154,2023950% (0)17%$968,992
20143,438349None17%$629,327
20133,0613110% (0)17%$519,196

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 42 drugs

Part D drugs prescribed in 2023
NuplazidParkinson's psychosis105$488,053$4,648
RytaryParkinson's96$238,339$2,483
GocovriNone44$135,978$3,090
TolcaponeNone14$110,803$7,915
Rasagiline MesylateNone160$60,960$381
Carbidopa-Levodopa ErNone602$52,949$88
Carbidopa-LevodopaNone718$51,538$72
NourianzNone19$48,327$2,544
EntacaponeNone83$23,235$280
Carbidopa-Levodopa-EntacaponeNone62$22,679$366
MyrbetriqNone17$21,173$1,245
AmantadineNone208$18,245$88
Pramipexole ErNone18$13,685$760
DonepezilNone287$6,510$23
MidodrineNone53$6,448$122
GabapentinNone181$4,789$26
RopiniroleNone54$3,917$73
RivastigmineNone13$3,688$284
EscitalopramNone165$2,846$17
TrazodoneNone97$2,832$29
MirtazapineNone84$2,756$33
Pramipexole DihydrochlorideNone92$2,491$27
QuetiapineNone92$1,971$21
ModafinilNone12$1,858$155
GlycopyrrolateNone42$1,852$44
PropranololNone42$1,846$44
Fludrocortisone AcetateNone37$1,814$49
Propranolol Hcl ErNone15$1,767$118
RivastigmineNone31$1,692$55
DoxepinNone49$1,125$23
Bupropion XlNone35$854$24
BaclofenNone17$824$48
Citalopram HbrNone50$599$12
SertralineNone45$548$12
PrimidoneNone16$489$31
ParoxetineNone23$416$18
Venlafaxine Hcl ErNone20$311$16
BupropionNone18$240$13
ClozapineNone32$176$5
ClonazepamNone25$171$7
DiazepamNone12$65$5
TrihexyphenidylNone12$55$5

2022: 44 drugs

Part D drugs prescribed in 2022
NuplazidParkinson's psychosis88$382,624$4,348
RytaryParkinson's109$231,346$2,122
TolcaponeNone16$119,201$7,450
GocovriNone42$116,485$2,773
Rasagiline MesylateNone180$86,224$479
Carbidopa-Levodopa ErNone709$60,574$85
Carbidopa-LevodopaNone821$59,314$72
NourianzNone16$41,978$2,624
EntacaponeNone99$35,714$361
Pramipexole ErNone48$25,295$527
Carbidopa-Levodopa-EntacaponeNone59$23,147$392
AmantadineNone191$18,290$96
OngentysNone11$9,857$896
MidodrineNone60$7,211$120
RivastigmineNone18$6,483$360
DonepezilNone323$5,304$16
MirtazapineNone85$4,266$50
Pramipexole DihydrochlorideNone105$4,018$38
EscitalopramNone204$3,569$17
GabapentinNone135$3,565$26
PropranololNone38$3,215$85
RopiniroleNone58$2,785$48
Fludrocortisone AcetateNone53$2,597$49
QuetiapineNone73$2,523$35
GlycopyrrolateNone39$2,460$63
TrazodoneNone121$2,453$20
SelegilineNone14$2,307$165
RivastigmineNone18$1,994$111
Propranolol Hcl ErNone19$1,795$94
TizanidineNone12$1,313$109
BaclofenNone23$1,103$48
Bupropion XlNone23$947$41
PrimidoneNone21$890$42
ParoxetineNone42$764$18
SertralineNone55$490$9
ModafinilNone16$484$30
BuspironeNone13$342$26
DoxepinNone22$332$15
Citalopram HbrNone44$313$7
ClonazepamNone30$312$10
Venlafaxine Hcl ErNone13$204$16
DiazepamNone20$129$6
TrihexyphenidylNone24$116$5
LorazepamNone13$46$4

2021: 42 drugs

Part D drugs prescribed in 2021
NuplazidParkinson's psychosis62$249,847$4,030
RytaryParkinson's125$208,503$1,668
Rasagiline MesylateNone195$103,847$533
Carbidopa-LevodopaNone912$78,016$86
TolcaponeNone18$69,237$3,846
Carbidopa-Levodopa ErNone717$62,084$87
GocovriNone24$44,896$1,871
Pramipexole ErNone55$32,751$595
Carbidopa-Levodopa-EntacaponeNone64$29,057$454
EntacaponeNone104$25,359$244
MyrbetriqNone38$24,284$639
AmantadineNone173$18,685$108
MidodrineNone89$9,559$107
RivastigmineNone20$7,454$373
Ropinirole ErNone20$5,189$259
MirtazapineNone117$4,558$39
DonepezilNone295$4,359$15
QuetiapineNone89$4,031$45
Pramipexole DihydrochlorideNone134$3,977$30
GabapentinNone177$3,951$22
PropranololNone70$3,948$56
Fludrocortisone AcetateNone59$3,108$53
EscitalopramNone159$2,454$15
RopiniroleNone53$2,335$44
RivastigmineNone23$2,121$92
GlycopyrrolateNone38$2,067$54
Propranolol Hcl ErNone22$1,805$82
TrazodoneNone120$1,637$14
Atropine SulfateNone12$1,574$131
TizanidineNone12$1,204$100
Bupropion XlNone20$892$45
ZonisamideNone16$888$56
ClozapineNone16$831$52
ParoxetineNone44$733$17
BaclofenNone27$703$26
Citalopram HbrNone61$503$8
PrimidoneNone20$465$23
ModafinilNone12$290$24
ClonazepamNone30$220$7
SertralineNone18$160$9
TrihexyphenidylNone15$88$6
LorazepamNone11$24$2

2020: 43 drugs

Part D drugs prescribed in 2020
NuplazidParkinson's psychosis49$172,840$3,527
TolcaponeNone19$158,455$8,340
RytaryParkinson's97$135,223$1,394
Rasagiline MesylateNone199$134,574$676
Carbidopa-LevodopaNone908$62,996$69
Carbidopa-Levodopa ErNone655$50,471$77
TetrabenazineNone11$33,679$3,062
Carbidopa-Levodopa-EntacaponeNone87$31,618$363
Pramipexole ErNone56$29,184$521
EntacaponeNone100$27,885$279
AmantadineNone220$21,001$95
MyrbetriqNone23$18,245$793
NourianzNone11$16,318$1,483
MidodrineNone98$10,251$105
RivastigmineNone15$5,397$360
Pramipexole DihydrochlorideNone142$4,684$33
Ropinirole ErNone29$4,526$156
MirtazapineNone117$3,654$31
Fludrocortisone AcetateNone48$3,641$76
DonepezilNone248$3,491$14
PropranololNone64$2,840$44
GabapentinNone165$2,705$16
GlycopyrrolateNone54$2,668$49
SelegilineNone12$2,079$173
RopiniroleNone33$1,790$54
TrazodoneNone106$1,615$15
EscitalopramNone118$1,559$13
ModafinilNone13$1,244$96
QuetiapineNone71$1,236$17
Atropine SulfateNone20$1,177$59
ParoxetineNone54$1,127$21
ClozapineNone23$1,079$47
TizanidineNone11$1,066$97
ZonisamideNone26$999$38
BaclofenNone24$740$31
PrimidoneNone24$725$30
Phenytoin Sodium ExtendedNone11$351$32
Citalopram HbrNone58$350$6
TrihexyphenidylNone25$329$13
PregabalinNone11$285$26
ClonazepamNone27$247$9
Venlafaxine Hcl ErNone18$180$10
LorazepamNone13$54$4

2019: 42 drugs

Part D drugs prescribed in 2019
Rasagiline MesylateNone219$165,807$757
RytaryParkinson's114$141,068$1,237
NuplazidParkinson's psychosis43$140,187$3,260
TolcaponeNone18$115,926$6,440
Carbidopa-LevodopaNone939$59,672$64
Carbidopa-Levodopa ErNone672$47,450$71
Carbidopa-Levodopa-EntacaponeNone102$39,656$389
Pramipexole ErNone54$32,052$594
EntacaponeNone114$28,977$254
AmantadineNone203$27,380$135
MyrbetriqNone35$22,969$656
MidodrineNone69$8,536$124
RivastigmineNone13$6,296$484
Pramipexole DihydrochlorideNone149$5,909$40
DonepezilNone245$4,993$20
GabapentinNone178$4,369$25
MirtazapineNone106$3,110$29
PropranololNone71$2,835$40
SelegilineNone13$2,613$201
TrazodoneNone130$2,432$19
Fludrocortisone AcetateNone46$2,430$53
GlycopyrrolateNone56$2,369$42
EscitalopramNone94$1,882$20
QuetiapineNone59$1,678$28
Propranolol Hcl ErNone13$1,611$124
RopiniroleNone40$1,591$40
TizanidineNone14$1,554$111
ParoxetineNone75$1,400$19
ModafinilNone12$1,351$113
Ropinirole ErNone13$1,232$95
ZonisamideNone18$1,048$58
BaclofenNone27$802$30
LevetiracetamNone13$766$59
Venlafaxine Hcl ErNone31$553$18
Phenytoin Sodium ExtendedNone16$502$31
Citalopram HbrNone54$378$7
Bupropion Hcl SrNone15$340$23
PrimidoneNone13$246$19
TrihexyphenidylNone30$204$7
SertralineNone29$190$7
ClonazepamNone19$91$5
LorazepamNone17$63$4

2018: 49 drugs

Part D drugs prescribed in 2018
Rasagiline MesylateNone269$233,778$869
TolcaponeNone22$176,505$8,023
RytaryParkinson's98$114,894$1,172
Carbidopa-LevodopaNone931$65,576$70
NuplazidParkinson's psychosis21$61,035$2,906
Carbidopa-Levodopa ErNone728$50,666$70
Carbidopa-Levodopa-EntacaponeNone125$45,504$364
EntacaponeNone99$40,799$412
Pramipexole ErNone48$31,707$661
AmantadineNone209$31,462$151
MyrbetriqNone35$23,603$674
AzilectNone20$18,462$923
Sinemet 25-100None16$9,445$590
RivastigmineNone17$8,710$512
Pramipexole DihydrochlorideNone170$7,583$45
MidodrineNone55$7,133$130
VesicareNone12$6,689$557
GabapentinNone169$4,868$29
Ropinirole ErNone12$3,843$320
DonepezilNone188$3,397$18
PropranololNone65$2,762$42
QuetiapineNone70$2,442$35
EscitalopramNone116$2,429$21
TrazodoneNone172$2,329$14
SelegilineNone11$2,215$201
Propranolol Hcl ErNone16$2,165$135
Fludrocortisone AcetateNone55$2,064$38
RivastigmineNone21$1,861$89
MirtazapineNone65$1,707$26
GlycopyrrolateNone37$1,542$42
ParoxetineNone89$1,213$14
RopiniroleNone38$1,182$31
TizanidineNone17$1,157$68
Bupropion Hcl SrNone14$1,017$73
Bupropion XlNone12$874$73
BaclofenNone35$825$24
LevetiracetamNone18$800$44
Venlafaxine Hcl ErNone45$676$15
ZonisamideNone12$635$53
PrimidoneNone18$500$28
ClozapineNone11$498$45
Polyethylene Glycol 3350None15$346$23
Citalopram HbrNone55$342$6
Phenytoin Sodium ExtendedNone12$326$27
ModafinilNone13$198$15
SertralineNone22$166$8
TrihexyphenidylNone30$157$5
ClonazepamNone21$131$6
LorazepamNone12$16$1

2017: 43 drugs

Part D drugs prescribed in 2017
Rasagiline MesylateNone246$239,788$975
AzilectNone85$106,455$1,252
RytaryParkinson's90$96,052$1,067
TolcaponeNone14$94,678$6,763
Carbidopa-Levodopa-EntacaponeNone115$70,434$612
Carbidopa-LevodopaNone1,016$63,992$63
EntacaponeNone97$46,279$477
NuplazidParkinson's psychosis17$40,515$2,383
Carbidopa-Levodopa ErNone586$37,791$64
AmantadineNone221$34,405$156
Pramipexole ErNone42$19,214$457
MyrbetriqNone22$13,177$599
Pramipexole DihydrochlorideNone219$8,755$40
VesicareNone18$6,779$377
MidodrineNone53$6,771$128
DonepezilNone250$4,093$16
Ropinirole ErNone13$3,807$293
GabapentinNone148$2,971$20
TrazodoneNone172$2,322$13
MirtazapineNone73$2,133$29
RopiniroleNone55$1,863$34
Fludrocortisone AcetateNone42$1,720$41
EscitalopramNone97$1,525$16
SelegilineNone18$1,494$83
Propranolol Hcl ErNone14$1,406$100
TizanidineNone13$1,319$101
GlycopyrrolateNone29$1,305$45
MemantineNone27$1,254$46
ModafinilNone13$1,237$95
ParoxetineNone86$1,086$13
PrimidoneNone21$1,030$49
QuetiapineNone90$988$11
Venlafaxine Hcl ErNone53$854$16
PropranololNone32$720$23
Bupropion XlNone13$549$42
Citalopram HbrNone64$512$8
ZonisamideNone12$421$35
AmitriptylineNone13$363$28
Phenytoin Sodium ExtendedNone11$305$28
BaclofenNone15$246$16
SertralineNone24$170$7
RizatriptanNone12$89$7
ClonazepamNone12$43$4

2016: 46 drugs

Part D drugs prescribed in 2016
AzilectNone349$412,220$1,181
EntacaponeNone117$61,953$530
RytaryParkinson's63$58,725$932
Carbidopa-LevodopaNone1,157$56,910$49
Carbidopa-Levodopa-EntacaponeNone109$43,844$402
AmantadineNone209$32,886$157
Carbidopa-Levodopa ErNone608$28,977$48
Mirapex ErNone19$15,418$811
Pramipexole DihydrochlorideNone244$14,461$59
Requip XlNone16$14,064$879
Pramipexole ErNone21$13,974$665
NeuproNone16$13,739$859
ComtanNone13$11,844$911
MyrbetriqNone27$9,961$369
Ropinirole ErNone21$6,673$318
MidodrineNone59$5,980$101
DonepezilNone273$5,321$19
ModafinilNone32$3,594$112
LinzessNone11$3,587$326
Propranolol Hcl ErNone30$3,307$110
SelegilineNone23$3,124$136
GabapentinNone139$2,926$21
BystolicNone11$2,564$233
TrazodoneNone152$2,468$16
RopiniroleNone61$2,456$40
MemantineNone28$2,329$83
MirtazapineNone48$1,447$30
EscitalopramNone74$1,352$18
Fludrocortisone AcetateNone32$1,332$42
PrimidoneNone38$1,291$34
QuetiapineNone46$1,145$25
PropranololNone32$1,072$33
Venlafaxine Hcl ErNone69$1,061$15
Trospium ChlorideNone13$793$61
AmitriptylineNone22$665$30
Bupropion Hcl SrNone16$640$40
ParoxetineNone57$575$10
LevetiracetamNone16$556$35
ZonisamideNone16$444$28
BaclofenNone14$322$23
Phenytoin Sodium ExtendedNone13$315$24
Citalopram HbrNone28$252$9
AlprazolamNone11$155$14
SertralineNone15$115$8
RizatriptanNone11$100$9
ClonazepamNone12$31$3

2015: 43 drugs

Part D drugs prescribed in 2015
AzilectNone319$322,795$1,012
TasmarNone22$251,795$11,445
Carbidopa-LevodopaNone1,132$56,613$50
EntacaponeNone130$52,055$400
Carbidopa-Levodopa-EntacaponeNone96$44,221$461
RytaryParkinson's48$38,105$794
AmantadineNone210$37,613$179
Carbidopa-Levodopa ErNone524$31,458$60
Pramipexole DihydrochlorideNone249$16,474$66
Pramipexole ErNone20$10,706$535
Requip XlNone15$10,565$704
Mirapex ErNone13$8,215$632
Ropinirole ErNone24$6,708$280
ModafinilNone24$6,195$258
DonepezilNone251$4,703$19
MyrbetriqNone11$4,493$408
RivastigmineNone27$4,029$149
Propranolol Hcl ErNone23$3,062$133
MidodrineNone36$2,973$83
Sinemet 25-100None11$2,629$239
SelegilineNone11$2,407$219
TizanidineNone12$2,309$192
RopiniroleNone58$2,096$36
GabapentinNone102$1,728$17
Venlafaxine Hcl ErNone79$1,674$21
TrazodoneNone126$1,463$12
GlycopyrrolateNone20$1,354$68
PropranololNone33$1,296$39
EscitalopramNone59$1,038$18
QuetiapineNone57$977$17
PrimidoneNone26$933$36
ZolmitriptanNone14$808$58
ParoxetineNone66$776$12
MirtazapineNone30$741$25
Fludrocortisone AcetateNone23$688$30
AmitriptylineNone24$589$25
ZolpidemNone13$465$36
Bupropion Hcl SrNone11$347$32
TrihexyphenidylNone26$310$12
Phenytoin Sodium ExtendedNone13$294$23
Citalopram HbrNone26$222$9
ClonazepamNone30$159$5
ClopidogrelNone12$91$8

2014: 32 drugs

Part D drugs prescribed in 2014
Azilect302$255,930$847
Tasmar26$83,856$3,225
Carbidopa-Levodopa956$62,828$66
Carbidopa-Levodopa-Entacapone77$40,330$524
Entacapone70$30,164$431
Amantadine146$27,828$191
Carbidopa-Levodopa Er448$25,016$56
Pramipexole Dihydrochloride223$13,481$60
Mirapex Er14$11,819$844
Ropinirole93$9,943$107
Exelon11$8,390$763
Rivastigmine19$5,382$283
Donepezil206$4,969$24
Quetiapine79$2,456$31
Sinemet 25-10011$2,142$195
Midodrine19$2,134$112
Paroxetine102$2,070$20
Gabapentin89$1,861$21
Propranolol Hcl Er12$1,447$121
Escitalopram55$1,403$26
Venlafaxine Hcl Er34$996$29
Trazodone83$814$10
Glycopyrrolate17$731$43
Primidone13$692$53
Mirtazapine32$638$20
Fludrocortisone Acetate16$542$34
Citalopram Hbr27$464$17
Phenytoin Sodium Extended12$374$31
Propranolol25$312$12
Trihexyphenidyl23$241$10
Clopidogrel15$195$13
Clonazepam25$115$5

2013: 30 drugs

Part D drugs prescribed in 2013
Azilect246$183,729$747
Carbidopa-Levodopa785$59,533$76
Tasmar29$43,593$1,503
Entacapone69$36,209$525
Carbidopa-Levodopa-Entacapone50$32,597$652
Amantadine135$27,201$201
Carbidopa-Levodopa Er426$25,950$61
Mirapex Er17$13,291$782
Pramipexole Dihydrochloride222$11,834$53
Requip Xl19$10,556$556
Ropinirole88$9,827$112
Stalevo 10016$8,622$539
Rivastigmine24$6,062$253
Donepezil229$5,296$23
Quetiapine43$5,132$119
Escitalopram64$3,018$47
Midodrine28$2,546$91
Paroxetine74$1,393$19
Gabapentin39$1,187$30
Propranolol33$1,017$31
Primidone21$735$35
Citalopram Hbr44$679$15
Mirtazapine47$664$14
Tizanidine12$555$46
Trazodone49$518$11
Trihexyphenidyl32$340$11
Fludrocortisone Acetate18$331$18
Phenytoin Sodium Extended12$293$24
Clopidogrel15$223$15
Clonazepam20$100$5

Money from drug and device companies

$155 in 2024

Industry payments by year
202413None$155
201911$25$25

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Boston ScientificNone$155
3 payments
  • Meals · 2024-10-02 · $21
  • Meals · 2024-10-02 · $42
  • Meals · 2024-10-02 · $92
See all 3 published payments
Every published payment
Boston ScientificMeals · 2024-10-02None$21
Boston ScientificMeals · 2024-10-02None$42
Boston ScientificMeals · 2024-10-02None$92
See earlier years (2019)

2019: $25

Payments by company in 2019
Acorda TherapeuticsInbrija$25
1 payment
  • Paid to speak or teach for Inbrija · 2019-02-15 · $25

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Neurocrine Biosciences, Inc. · A Randomized, Placebo Surgery Controlled, Double-Blinded, Multi-Center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of Vy-Aadc02 in Advanced Parkinson?S Disease With Motor Fluctuations · 2020Their institution$449,037
Neurocrine Biosciences, Inc. · A Randomized, Placebo Surgery Controlled, Double-Blinded, Multi-Center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of Vy-Aadc02 in Advanced Parkinson'S Disease With Motor Fluctuations · 2019Their institution$286,144
Neurocrine Biosciences, Inc. · A Randomized, Placebo Surgery Controlled, Double-Blinded, Multi-Center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of Vy-Aadc02 in Advanced Parkinson?S Disease With Motor Fluctuations · 2021Their institution$113,464
Neurocrine Biosciences, Inc. · An Observational, Long-Term Extension Study for Participants of Prior Vy-Aadc01 Or Vy-Aadc01 Clinical Studies · 2019Their institution$95,761
Neurocrine Biosciences, Inc. · An Observational, Long-Term Extension Study for Participants of Prior Vy-Aadc01 Or Vy-Aadc01 Clinical Studies · 2020Their institution$77,279
Bayer Healthcare Pharmaceuticals Inc. · Bay 3657334, Long-Term Safety and Efficacy Follow-Up of Ab-1005 Gene Transfer Study Participants With Parkinsons Disease Or Multiple System Atrophy · 2025Their institution$29,655
Neurocrine Biosciences, Inc. · An Observational, Long-Term Extension Study for Participants of Prior Vy-Aadc01 Or Vy-Aadc01 Clinical Studies · 2021Their institution$28,580

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1437186855
Licence
CA G76788California G76788: Current · expires 2027-05-31
Trained
Js Weill Medical College, Cornell University, 1991 · 35 years ago
Group
UCSF Medical Group Business Services · University of California San Francisco
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00G767880
Taxonomy
Neurology (2084N0400X)
Mailing address
1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA, 94143
NPI first listed
2006-06-28
NPI last updated
2007-07-09

This is when the NPI record was last certified, not a medical board exam.